The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre

被引:77
|
作者
Salamone, Dominic [1 ]
Rivellese, Angela Albarosa [1 ,2 ]
Vetrani, Claudia [1 ,2 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, 5 Sergio Pansini, I-80131 Naples, Italy
[2] Univ Naples Federico II, Task Force Microbiome Studies, Naples, Italy
关键词
Gut microbiota; Short-chain fatty acids; Type; 2; Diabetes; Insulin resistance; Glucose tolerance; Dietary fibre; INSULIN SENSITIVITY; MEDITERRANEAN DIET; BODY-WEIGHT; GLUCOSE; HEALTH; ASSOCIATION; IMPROVEMENT; PROPIONATE; METABOLISM; METAGENOME;
D O I
10.1007/s00592-021-01727-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gut microbiota and its metabolites have been shown to influence multiple physiological mechanisms related to human health. Among microbial metabolites, short-chain fatty acids (SCFA) are modulators of different metabolic pathways. On the other hand, several studies suggested that diet might influence gut microbiota composition and activity thus modulating the risk of metabolic disease, i.e. obesity, insulin resistance and type 2 diabetes. Among dietary component, dietary fibre may play a pivotal role by virtue of its prebiotic effect on fibre-fermenting bacteria, that may increase SCFA production. The aim of this review was to summarize and discuss current knowledge on the impact of dietary fibre as modulator of the relationship between glucose metabolism and microbiota composition in humans. More specifically, we analysed evidence from observational studies and randomized nutritional intervention investigating the relationship between gut microbiota, short-chain fatty acids and glucose metabolism. The possible mechanisms behind this association were also discussed.
引用
收藏
页码:1131 / 1138
页数:8
相关论文
共 50 条
  • [31] Evidence for the Gut Microbiota Short-Chain Fatty Acids as Key Pathophysiological Molecules Improving Diabetes
    Puddu, Alessandra
    Sanguineti, Roberta
    Montecucco, Fabrizio
    Viviani, Giorgio Luciano
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [32] Significance of Gut Microbiota and Short-Chain Fatty Acids in Heart Failure
    Zhao, Peng
    Zhao, Suhong
    Tian, Jinwei
    Liu, Xinxin
    NUTRIENTS, 2022, 14 (18)
  • [33] Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy
    Lingxiong Chai
    Qun Luo
    Kedan Cai
    Kaiyue Wang
    Binbin Xu
    BMC Nephrology, 22
  • [34] Reduced fecal short-chain fatty acids levels and the relationship with gut microbiota in IgA nephropathy
    Chai, Lingxiong
    Luo, Qun
    Cai, Kedan
    Wang, Kaiyue
    Xu, Binbin
    BMC NEPHROLOGY, 2021, 22 (01)
  • [35] The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health
    Nogal, Ana
    Valdes, Ana M.
    Menni, Cristina
    GUT MICROBES, 2021, 13 (01) : 1 - 24
  • [36] Free Fatty Acids Profiles Are Related to Gut Microbiota Signatures and Short-Chain Fatty Acids
    Rodriguez-Carrio, Javier
    Salazar, Nuria
    Margolles, Abelardo
    Gonzalez, Sonia
    Gueimonde, Miguel
    de los Reyes-Gavilan, Clara G.
    Suarez, Ana
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [37] Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health
    Chambers E.S.
    Preston T.
    Frost G.
    Morrison D.J.
    Current Nutrition Reports, 2018, 7 (4) : 198 - 206
  • [38] The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids
    Felizardo, R. J. F.
    Watanabe, I. K. M.
    Dardi, Patrizia
    Rossoni, L. V.
    Camara, N. O. S.
    PHARMACOLOGICAL RESEARCH, 2019, 141 : 366 - 377
  • [40] Role of dietary fiber and short-chain fatty acids in the colon
    Andoh, A
    Tsujikawa, T
    Fujiyama, Y
    CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (04) : 347 - 358